跳至主要内容
临床试验/IRCT20120415009472N25
IRCT20120415009472N25已完成2 期

Assessing the effect of purslane supplementation on clinical outcomes, inflammatory and oxidative stress markers in patients with rheumatoid arthritis: A parallel double-blinded randomized controlled clinical trial

Iran University of Medical Sciences0 个研究点目标入组 86 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Diagnosis of Rheumatoid Arthritis Based on American College of Rheumatology (ACR) Criteria(If there are at least four criteria for six weeks of the criteria 1- Morning dryness for at least one hour in three joints or more 2- Arthritis of three joint areas or more 3- Arthritis of the hand joints 4- Symmetric arthritis 5- Rheumatoid nodules 6- Positive rheumatoid factor 7- Typical radiographic changes in the wrist and hand)
  • The duration of the disease is at least one year
  • The patient expresses his / her consent to participate in the study

排除标准

  • Having any of the diseases of diabetes, hypertension, thyroid disorder and kidney failure and Liver dysfunction
  • Taking supplements (omega 3, antioxidants, etc.) in the last three months
  • Taking contraceptives
  • Changes in the amount of medication taken in the past month
  • Patients who have followed a specific diet in the last three months
  • Pregnancy and lactation

研究者

相似试验